Search results for "PARKIN"

showing 10 items of 468 documents

MAGNETIC RESONANCE IMAGING–GUIDED FOCUSED ULTRASOUND THALAMOTOMY IN PATIENT WITH TREMOR COMBINED WITH PARKINSONISM: RETREATMENT AFTER BENEFIT DECAY

2019

Background In recent years, transcranial Magnetic Resonance-guided Focused UltraSounds (tcMRgFUS) treatments for functional neurological disorders are giving a new thrust to the field of therapeutic brain lesioning. This technique has been proven safe and effective in selected patients. Here we present the case of a patient affected by tremor combined with parkinsonism who underwent a second tcMRgFUS thalamotomy because of relapsing tremor after a few months from the first tcMRgFUS treatment. Materials and Methods A 72-year-old, right-handed man, who came to our observation because of a disabling tremor affecting mainly his upper right limb and refusing any invasive surgical procedure. His …

focused ultrasound Parkinsonism thalamotomy thermal ablation retreatemtnSettore MED/27 - NeurochirurgiaSettore MED/37 - NeuroradiologiaSettore MED/26 - NeurologiaSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Musical Feedback: a new strategy in gait training for Parkinson’s Disease Patients

2016

Rhythmic auditory stimulation (RAS) for gait training in Parkinson’s disease has been applied successfully over the last three decades. The purpose of this study is to investigate the effectiveness of an extended concept of RAS, which is not limited to musical stimulation, but also includes musical feedback. In our study the comparison between RAS, musical feedback (MF), and no musical stimulation (NM) is conducted on a sample of 20 idiopathic Parkinsonian patients in a randomized cross-over design. Each patient has the task to walk for six minutes for each condition, focusing on stride length. The patient is instructed to make long steps and is connected with a software that is able to rec…

gait trainingParkinsonmusical feedbackbehavioral disciplines and activitieshuman activitieshumanitiesRAS
researchProduct

Classification of healthy, Alzheimer and Parkinson populations with a multi-branch neural network

2022

Signal processing, for delimitation of the target events and parametrization, is usually required when instrumented assessment is conducted to determine an individual’s functional status. However, these procedures may rule out relevant information obtained by sensors. To prevent this, the use of models based on neural networks that automatically extract relevant features from the raw signal may improve the characterization of the functional status. Thus, the aim of the study was to determine the classification accuracy of a multi-head convolutional layered neural network (CNN) using a simple functional mobility test in people with different conditions. The raw data from an inertial sensor e…

inertial sensorparkinson’s diseaseSignal Processingalzheimer diseaseBiomedical EngineeringHealth Informaticsfunctional assessmentmulti-branch convolutional classifierUNESCO::CIENCIAS TECNOLÓGICASBiomedical Signal Processing and Control
researchProduct

Advancing stem cells: New therapeutic strategies for treating central nervous system disorders

2018

In this special issue, we explore new methods and knowledge to improve stem cell transplantation in diseases and conditions such as stroke, PD, and depression. Advancing the conventional idea regarding cell replacement in stem cell therapy, stem cells may also transfer healthy mitochondria to diseased ischemic neurons in stroke and improve the therapeutic time window of tissue plasminogen activator (tPA) in a conjunctive therapy for stroke, and human Wharton’s Jelly-derived mesenchymal stromal cells (hWJ-MSCs) may rely mainly on trophic factor secretion to induce neuroprotective effects. In addition, trophic factors such as neurotrophin-4/5 (NT-4/5) and glial cell line-derived neurotrophic …

lcsh:Diseases of the circulatory (Cardiovascular) systemParkinson's diseaselcsh:Medical technologyCentral nervous systemBioinformaticsTissue plasminogen activatorParkinson’s DiseaseWharton’s Jelly‑derived Mesenchymal Stromal CellText miningMitochondrial TargetingmedicineGlial cell line-derived neurotrophic factorStrokeDepression (differential diagnoses)biologybusiness.industryDepressionGeneral Medicinemedicine.diseaseGDNFStrokemedicine.anatomical_structureEditoriallcsh:R855-855.5lcsh:RC666-701White Matter RepairTissue Plasminogen Activatorbiology.proteinsuperparamagnetic iron oxideStem cellbusinessCosmic Radiationmedicine.drug
researchProduct

Motor imagery in unipolar major depression

2014

International audience; Background: Motor imagery is a potential tool to investigate action representation, as it can provide insights into the processes of action planning and preparation. Recent studies suggest that depressed patients present specific impairment in mental rotation. The present study was designed to investigate the influence of unipolar depression on motor imagery ability. Methods: Fourteen right-handed patients meeting DSM-IV criteria for unipolar depression were compared to 14 matched healthy controls. Imagery ability was accessed by the timing correspondence between executed and imagined movements during a pointing task, involving strong spatiotemporal constraints (spee…

major depressive disorderspeed/accuracy trade offPREDICTIONCognitive NeuroscienceMULTIPLE-SCLEROSISPERFORMANCEBehavioral NeuroscienceNeuropsychology and Physiological Psychologymotor imageryTEMPORAL FEATURESPARKINSONS-DISEASEmovement speedSIMULATIONmental chronometryHAND MOVEMENTSARMPSYCHOMOTOR RETARDATIONANHEDONIA[ SCCO ] Cognitive scienceNeuroscience
researchProduct

Changes in Oxidative Stress Index and Lipid Peroxidation Product in the Brain of Rats with Lesion of Central Dopaminergic System after Propofol Admin…

2019

Propofol is a commonly used intravenous anesthetic agent with antioxidant properties. However, the effect of propofol on oxidative stress index (OSI) and lipid peroxidation in Parkinson’s disease is still unknown. The present study aimed to evaluate the effect of propofol on OSI and malondialdehyde (MDA) level in the selected brain regions of the rats with Parkinson’s disease (PD). 32 male Wistar rats were divided into four groups: I- control group, II- group with PD, III-control group with propofol, IV-PD group with propofol. 60mg/kg of propofol was given to the 8-weeks-old rats intraperitoneally, and the selected parts of the rats’ brains (frontal cortex, striatum, thalamus and hippocampu…

malondialdehydeMicrobiology (medical)propofolbusiness.industrylcsh:RDopaminergiclcsh:MedicinePharmacologymedicine.disease_causeParkinson diseaseLipid peroxidationLesionchemistry.chemical_compoundInfectious Diseaseschemistryoxidative stress indexmedicinemedicine.symptomPropofolbusinessOxidative stressmedicine.drugPostępy Higieny i Medycyny Doświadczalnej
researchProduct

Changes in Oxidative Stress Index and Lipid Peroxidation Product in the Brain of Rats with Lesion of Central Dopaminergic System after Propofol Admin…

2019

Propofol is a commonly used intravenous anesthetic agent with antioxidant properties. However, the effect of propofol on oxidative stress index (OSI) and lipid peroxidation in Parkinson’s disease is still unknown. The present study aimed to evaluate the effect of propofol on OSI and malondialdehyde (MDA) level in the selected brain regions of the rats with Parkinson’s disease (PD). 32 male Wistar rats were divided into four groups: I- control group, II- group with PD, III-control group with propofol, IV-PD group with propofol. 60mg/kg of propofol was given to the 8-weeks-old rats intraperitoneally, and the selected parts of the rats’ brains (frontal cortex, striatum, thalamus and hippocampu…

malondialdehydeParkinson diseasepropofoloxidative stress indexPostępy Higieny i Medycyny Doświadczalnej
researchProduct

Ethical challenges in cell-based interventions for neurological conditions: some lessons to be learnt from clinical transplantation trials in patient…

2009

medicine.medical_specialtyCharacterParkinson's diseaseCell TransplantationDopaminePsychological interventionIndividualityTransplantation AutologousEthics ResearchCognitionCentral Nervous System DiseasesFetal Tissue TransplantationMesencephalonmedicineHumansIn patientBrain Tissue TransplantationPsychiatryIntensive care medicineBehaviorClinical Trials as Topicbusiness.industryHealth PolicyParkinson Diseasemedicine.diseaseSelf ConceptTransplantationIssues ethics and legal aspectsAffectAdrenal MedullabusinessPersonalityThe American journal of bioethics : AJOB
researchProduct

Will it ever become possible to prevent dopaminergic neuronal degeneration?

2008

Parkinsons disease (PD) is the second leading age-related degenerative brain disease in the world affecting millions of people. This neurological disorder disrupts the quality of life of patients and their families, exerts an enormous emotional and physical strain on caregivers, and has a large cost for society. Moreover, the increasing numbers of elderly people in the population will result in a sharp increase in the prevalence of PD. The understanding of its pathophysiology and treatment has advanced at a very impressive rate during past decades. Nevertheless, PD is still fatal and there is at present no cure for it. Furthermore, there are no proven therapies for prevention of PD and alth…

medicine.medical_specialtyDopaminePopulationNeurological disorderDiseaseNeuroprotectionSettore BIO/09 - FisiologiaNeuroprotective agentsRisk FactorsmedicineAnimalsHumansNeuronal degenerationNeurodegeneration Neuroprotection Parkinson's diseaseIntensive care medicineeducationPharmacologyNeuronseducation.field_of_studyCell Deathbusiness.industryGeneral NeuroscienceDopaminergicNeurodegenerative DiseasesParkinson's disease -- Treatmentmedicine.diseaseBrain diseaseNeuroprotective AgentsDrug developmentbusinessNervous system -- Degeneration
researchProduct

No paradox, no progress: inverse cancer comorbidity in people with other complex diseases.

2011

Salvador Martínez [et al.]. 5 p., 2 tables and references.

medicine.medical_specialtyDown syndromeAnorexia NervosaNeuregulin-1DiseaseComorbidity03 medical and health sciences0302 clinical medicineAlzheimer DiseaseNeoplasmsEpidemiologymedicineHumansGenetic Predisposition to DiseasePsychiatryComputingMilieux_MISCELLANEOUS030304 developmental biology0303 health sciencesbusiness.industryCancerParkinson Diseasemedicine.disease[SDV.BIBS]Life Sciences [q-bio]/Quantitative Methods [q-bio.QM]Comorbidity3. Good healthOncologySchizophreniaAnorexia nervosa (differential diagnoses)SchizophreniaAlzheimer's diseaseDown Syndromebusiness030217 neurology & neurosurgeryChromosomes Human Pair 8The Lancet. Oncology
researchProduct